Clifford Chance advised Sanofi on the deal.Global healthcare company Sanofi announced the acquisition of exclusive rights to develop and commercialise aficamten in Greater China from Corxel…
Sanofi’s Acquisition Of Aficamten Rights From Corxel Pharmaceuticals
